Filtered By:
Source: Molecular and Cellular Endocrinology
Drug: Evista
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Bazedoxifene and raloxifene protect neocortical neurons undergoing hypoxia via targeting ER α and PPAR-γ
This study provides prospects for the development of a new therapeutic strategies against hypoxic brain injury that selectively target ERα and/or PPAR-γ.
Source: Molecular and Cellular Endocrinology - August 31, 2017 Category: Endocrinology Source Type: research
